Lengerli D - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.

Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D, O'Quinn EC, Romeo MJ, Caliskan B, Banoglu E, Aksoy S, Uner A, Sahin O. Saatci O, et al. Among authors: lengerli d. Cell Death Differ. 2023 May;30(5):1305-1319. doi: 10.1038/s41418-023-01140-1. Epub 2023 Mar 2. Cell Death Differ. 2023. PMID: 36864125 Free PMC article.

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity.

Turanlı S, Nalbat E, Lengerli D, İbiş K, Güntekin Ergün S, Akhan Güzelcan E, Muyan M, Cetin-Atalay R, Çalışkan B, Banoglu E. Turanlı S, et al. Among authors: lengerli d. ACS Omega. 2022 Oct 3;7(41):36206-36226. doi: 10.1021/acsomega.2c03405. eCollection 2022 Oct 18. ACS Omega. 2022. PMID: 36278052 Free PMC article.

The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool.

Lengerli D, Ibis K, Nural Y, Banoglu E. Lengerli D, et al. Expert Opin Drug Discov. 2022 Nov;17(11):1209-1236. doi: 10.1080/17460441.2022.2129613. Epub 2022 Oct 5. Expert Opin Drug Discov. 2022. PMID: 36164263 Review.

Crystal structure and Hirshfeld surface analysis of 4-(4-chloro-phen-yl)-5-methyl-3-{4-[(2-methyl-phen-yl)meth-oxy]phen-yl}-1,2-oxazole.

Aydin A, Akkurt M, Turanli S, Lengerli D, Banoglu E, Ozcelik ND. Aydin A, et al. Among authors: lengerli d. Acta Crystallogr E Crystallogr Commun. 2021 Mar 5;77(Pt 4):346-350. doi: 10.1107/S2056989021002383. eCollection 2021 Apr 1. Acta Crystallogr E Crystallogr Commun. 2021. PMID: 33936755 Free PMC article.

A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.

Akbulut O, Lengerli D, Saatci O, Duman E, Seker UOS, Isik A, Akyol A, Caliskan B, Banoglu E, Sahin O. Akbulut O, et al. Among authors: lengerli d. Mol Cancer Ther. 2020 Jun;19(6):1243-1254. doi: 10.1158/1535-7163.MCT-19-0957. Epub 2020 Mar 26. Mol Cancer Ther. 2020. PMID: 32217742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5 results

Search Page

Filters